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ABSTRACT
Five compounds, namely 5,5’-benzene-1,4-diylbis(1,3,4-oxadiazole-2-thiol)6 and 5,5’-benzene-1,4-diylbis(1H-1,2,4-triazole-3-thiol) 7a
and its derivatives 7b–d were synthesized. Two related S-nucleosides 9 and 10 have been prepared from 6 and 7a. Some of these
synthesized compounds were tested in vitro by spotting on Mueller Hinton Agar medium against some Gram-positive bacteria,
Staphylococcus aureus and Enterococcus faecalis and three Gram-negative bacteria Escherichia coli, Pseudomonasaeruginosa,
Pseudomonas fluorescens and compared with the known antibiotics cephalosporin (cefotaxim) and gentamycin. Compound 6
showed significant inhibitory activity against Gram-positive E. faecalis and Gram-negative E. coli bacteria while the others have
shown variable inhibition activity.
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1. Introduction
The emergence of bacterial resistance to Ä-lactam antibiotics,
macrolides, quinolones and vancomycin is becoming a major
worldwide health problem, with antibiotic resistance among
Gram-positive bacteria becoming increasingly serious.1,2 These
facts inspired us to synthesize new compounds with potential
anti-bacterial and anti-viral inhibitory effect such as 1,3,4-oxa-
diazoles, 1,2,4-triazoles and nucleosides related to them.
Nucleoside analogues constitute an important class of therapeu-
tic agents in the treatment of cancers and viral infections. The
mode of action of these derivatives is based upon their
intracellular conversion to their phosphorylated forms (nucleo-
tides), which can be used in cellular biosynthesis.3,4 The literature
shows intensive work describing various kinds of nucleoside
analogues concerning chemical modification of nucleobases5–7
and/or the sugar moieties,8–10 and more complicated analogs like
dinuclear,11 single or multiple-headed nucleosides.12–13 Some
related single S-nucleosides in two instances were found to have
a wide range of biological activity, such as enzyme inhibitory,
anti-bacterial,14,15 anti HIV-1 inhibitory,16 anti-tumor,17 anti-
inflammatory,18 anti-fungal19 and anti-cancer action.20 Although
a tremendous amount of work has been done in the synthesis of
new series of nucleoside analogues, none regarding synthesis
and biological activity of multiple S-nucleosides were reported.
This prompted us to choose synthesizing the intermediates
5,5’-benzene-1,4-diylbis(1,3,4-oxadiazole-2-thiol) 6 and
5,5’-benzene-1,4-diylbis(1H-1,2,4-triazole-3-thiol) 7a, starting
from terephthalic acid (TPA), as precursors for building multiple
S-nucleosides 9 and 10. TPA has been considered to be
non-genotoxic chemical compound and it is a mild respiratory
tract and eye irritant, but it was found to be toxic at high doses.21
Studies have shown that variation of the carboxylate functions
of TPA resulted in a reduced ulcerogenic effect, while retaining
the anti-inflammatory and analgesic activities.22–25 Furthermore,
substituted 1,3,4-oxadiazole and 1,2,4-triazole derivatives have
been reported to show a broad spectrum of biological activities
including anticancer,26,27 antibacterial,28–30 anti-inflammatory and
analgesic effects.22 We anticipated that the oxadiazole and
triazole derivatives of terephthalic acid may show significant
biological activity. Thus all the synthesized derivatives from TPA
represented by compounds 4–7c were synthesized for evalua-
tion of their preliminary in vitro antibacterial activity against
some Gram-positive and Gram-negative bacterial strains.
2. Results and Discussion
2.1. Synthesis
The bisoxadiazole 6 was synthesized according to Scheme 1.
The ester 2 has been prepared by two methods, either by
refluxing the acid 1 in methanol with catalytic amount of
sulphuric acid or by treating TPA with thionyl chloride in
methanol under reflux. In both cases the yield exceeded 90 %.
The hydrazide 4 was isolated in 85 % yield when the ester
was refluxed with 64 % hydrazine. The yield was reduced appre-
ciably when the ester was treated with 90 % hydrazine. The
bisoxadiazole 6 was obtained after refluxing the hydrazide 4
with CS2 in methanol in presence of sodium hydroxide to give 6
as a high melting yellow crystallinein 80 % yield.31–33 The
bisoxadiazole 6 exists largely in the form of thione with a trace of
thiol form as shown by strong absorption in IR at 1421 cm–1
for C=S and a weak peak appeared at 2360 cm–1 for SH stretching
band. This was confirmed by 1H-NMR and 13C-NMR as exhibited
by C=S signal at 206 ppm.39 The mass spectrum showed molecular
ion at m/z 277.9933.
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The synthesis of bistriazole 7a34–38 was achieved via formation
of terephthalolyl chloride 3 which was prepared from TPA and
thionyl chloride in an excellent yield. The yields varied between
95 % and 98 % depending upon the concentration of thionyl
chloride in the reaction medium. Using excess of thionyl chlo-
ride without any other solvent gave higher percentage of 3 and
shortened the reaction time from 24 h to 5 h. Two pathways A
and B were followed to reach 7a from 3. Pathway A, the direct
method, consisted of treating 3 with thiosemicarbazide in
pyridine solution, the adduct without isolation was then treated
with methanolic solution of freshly prepared sodium methoxide
to give 7a in good yield (72 %). IR spectrum of the product 7a
suggested the thione form predominated, as exhibited by the
characteristic band for C=S at 1230 cm–1.39
The second pathway B, the indirect method, used to the
synthesize 7a, included the preparation and isolation of 5 by
means of treating 3 with thiosemicarbazide. The structure 5 was
established based on IR, 1H-NMR and 13C-NMR spectroscopy. Its
IR spectrum had the characteristic bands for NH, CON and
CSNH at 3275, 1669 and 1267 cm–1, respectively. 1H-NMR
confirmed the presence of NH by the signal at 10.49 ppm.
13C-NMR had signals at 127.6 ppm (for aromatic carbons),
165.0 ppm (CON) and 181.9 ppm (for the thiourea carbon
CSNH2).
39 Base-catalyzed cyclization of 5 in the presence of KOH
gave 7a in an excellent yield of 96 %, identical to that obtained by
the direct method. The product 7a was poorly soluble in CHCl3
and DMSO which made it difficult to perform 1H-NMR and
13C-NMR spectroscopic measurements. Monomethyl 7b and
dimethyl 7c derivatives were prepared to overcome this problem.
The monomethyl triazole 7b was prepared in 75 % yield by treat-
ing 7a with one molar equivalent of dimethylsulfate. 1H-NMR
spectrum of 7b in DMSO exhibited a singlet at 3.2 ppm
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Scheme 1
Synthetic pathway for the preparation of compounds 6, 7a–d, 8, 9 and 10.
integrated for 6H assigned for the two S-CH3 groups.
13C-NMR
spectrum of the same compound exhibited the characteristic
carbons at Ç 15.1 (S-CH3), 127.6 (aromatic), 131.6 (aromatic), 159.7
(C-3 heterocyclic) and 160.6 ppm (C-5 heterocyclic).37 Its mass
spectrum displayed MH+ at m/z 305.0651 which is in accord with
the molecular formula C12H13N6S2. The dimethyl triazole 7c was
obtained in 72 % yield by treating 7a with a six-fold excess of
dimethylsulfate. Compound 7c had a lower m.p. of 193–197 °C,
and gave an 1H-NMR spectrum which exhibited two singlets at
3.90 and 2.95 ppm, each integrated for H. The first was attributed
to the two N-CH3 groups and the other to the two S-CH3 groups.
13CNMR for had heteroaromatic C signals at 161.3, 153.6, 131.4,
126.2, 35.3 and 15.8 ppm.40 The mass spectrum of compound 7c
displayed MH+at m/z 333.0951 which is in agreement with the
molecular formula C14H17N6S2.
5,5’-Benzene-1,4-diylbis(1-amino-1H-1,2,4-triazole-3-thiol)
7d41–43 was prepared by treating bisoxadiazole 6 with hydrazine.
IR spectroscopy showed an absorption band at 2360 cm–1 for SH
and 1423 cm–1 for C=S, while 1H-NMR exhibited a signal at
5.80 ppm for NH2. The mass spectrum of 7d showed at m/z
306.0475 which is in agreement with its molecular formula
C10H10N8S2.
The primary attempt to form the S-nucleosides 9 and 10 was
done by linking oxadiazole 6 and triazole 7a with gluco-
pyranosyl bromide 8 by an aid of triethylamine at room temper-
ature for 24 hours. TLC, IR and 1H-NMR for 9 and 10 showed
glycosidation of the SH of 6 and 7a by means of disappearance of
both the SH band in the IR spectrum and SH signal in the
1H-NMR spectrum at Ç 2.51 ppm, with the appearance of sugar
protons (see experimental section). The incorporation of sugar
moieties was also supported by mass spectra of 9 which showed
MH+at m/z 939.1917 and of 10, having MH+ at m/z 937.2238.
3. Antibacterial Evaluations
Since TPA is known to be a non-genotoxic compound and
anti-bacterial inhibitor,21 the inhibitory effect of its derivatives
4–7a–c in DMSO (10 % v:v)were tested upon in vitro against
Gram-positive, Staphylococcus aureus ATCC25923 and Entero-
coccus faecalis ATTC 29212 and three Gram-negative bacteria Esche-
richia coli ATCC 25924, Pseudomonas aeruginosa ATCC 10145,
Pseudomonas fluorescens. DMSO, which is known as bacterial
static in the above-mentioned concentration, was used as nega-
tive control and standard disks (Mast Diagnostics, UK), satu-
rated with known antibiotic Cefotaxim and Gentamycin as posi-
tive control were applied. After incubation at 37 °C for 24 h, the
zone of inhibition of growth around each disk was measured in
millimetres and zone diameters were interpreted in accordance
with CLSI and NCCLS (for Campylobacter spp.) guidelines (CLSI,
2006; NCCLS, 2003, 2005).44–46 The experiments were performed
in duplicates and the average results are summarized in Table 1.
Furthermore, the minimum inhibition concentrations were
determined in triplicates against the test bacteria and the average
results shown in Table 2. Cefotaxim’s MIC interpretive break-
points were used as standard as follows: ¡1 µg mL–1, susceptible;
—1–4 µg mL–1, intermediate; —4 µg mL–1, resistant.50,51
Hydrazide 4 and thiosemicarbazide 5 showed no effect on any
examined bacteria at concentration higher than 5.0 µg mL–1.
Compound 6 showed an intermediate effect on E. faecalis and
E. coli at concentration (1.25 µg mL–1), triazole 7a exhibited
asimilar effect on P. aeruginosa while methyl triazole 7b showed a
similar effect on P. aeruginosa and E. coli at the same concentra-
tion. The highest effect was observed by dimethyl triazole 7c
upon E. coli at lowest concentration (0.36 µg mL–1).
4. Experimental
4.1. General
All reactions were monitored by TLC, silica gel F254, made by
Merck, Germany. The melting points were measured with a
BÜCHI 540 melting point apparatus and are uncorrected. The
IR spectra were recorded using KBr discs in a GENESIS II FTIR
spectrophotometer, in units of cm–1. The 1H and 13C NMR spectra
in 1d were recorded on a Bruker AC 250 M spectrometer in either
DMSO-d6 or CDCl3 and referenced to TMS. Coupling constants,
J, are given in Hz, and chemical shifts in ppm. The mass spectra
were recorded on a Micro Tof-Q 98 mass spectrometer at Faculté
de chimie des matériaux, Université de Luxembourg, Luxem-
bourg’, using glycerol as matrix, and reported in units of m/z.
Microorganisms in this study were supplied by the university
hospital of Oran and identified by the laboratory of applied
microbiology, University of Oran EsSenia. The Mueller Hinton
medium was supplied by (Difco).
4.2. Dimethyl Terephthalate 2
Method A: terephthalic acid 1 (18.33 g, 0.05 mol), methanol
(200 mL) and H2SO4 (5 mL) were heated under reflux for 4 h. Solid
NaHCO3 was added to neutralize the acid to pH 7 and filtered off.
The filtrate was evaporated to dryness under vacuum to give
white solid, recrystallized from ether-petroleum ether 40–60 °C
to give colourless crystalline dimethyl terephthalate 2 (19.25 g,
93 %). M.p. 141–142 °C (lit. 141–142 °C).52 ÇH(DMSO-d6, 250 MHz)
8.1 (4H, s, H-aromatic), 3.9(6H,s, OCH3); ÇC(DMSO-d6, 62.5 MHz)
51.6, 135.0, 128.0 and 165.0.
Method B: TPA1 (18.33 g, 0.05 mol), methanol (200 mL) and
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Table 1 Antibacterial screening of compounds 4–7a–c* by a disk diffusion method in Mueller Hinton medium incubated at 37 °C,
measured in mm.
Compound Gram-positive Gram-negative
S. aureus E. faecalis E. coli P. aeruginosa P. fluorescens
4 – – – – –
5 10(R)† – – – –
6 9(R) 16(S) 23(S) – 9(R)
7a – – – 10(R) –
7b 10(R) 10(R) 9(R) 12(R) 10(R)
7c – 9(R) 9(R) 12(R) 9(R)
DMSO (10 % v:v) – – – – –
Gentamycin 29(S) 29(S) 25(S) 12(R) 11(R)
Cefotaxim 33(S) 32(S) 29(S) 20(I) 11(R)
Key to the inhibition zones activities. * Concentration 10 µg mL–1. †Abbreviations: S, susceptible; I, intermediate ; R, resistant. For gentamycin:
S —15 mm; I = 13–14 mm; R ¡12 mm, and for cefotaxim: S —32 mm; I = 15–22 mm; R ¡14 mm.50
thionyl chloride, (20 mL) were heated under reflux for 1 h.
Working up as above, gave similar results.
4.3. Terephthalolyl Dichloride 3
Method A: TPA (0.50 g, 0.01 mol) and thionyl chloride (15 mL)
were heated under reflux for 5 h until the acid was dissolved
completely. Excess reagent was removed under vacuum to give
the bis-acyl chloride terephthalate 3 as yellowish solid (0.60 g,
98 %), m.p. 82–84.5 °C (lit. 79–81 °C); ÇH(DMSO-d6, 250 MHz) 8.21
(4H, s, H-aromatic); ÇC(DMSO-d6, 62.5 MHz) 130.1, 138.0 and
166.3.
Method B. TPA (8.30 g, 0.50 mol), chloroform (100 mL) and
thionyl chloride (16 mL), added to it DMF (5 mL) dropwise while
stirring at room temperature. The mixture was refluxed for 24 h
at 80 °C. The solvents were removed under vacuum to give a
yellowish crystalline 3 (9.65 g, 95 %), m.p. 82–84.5 °C.
4.4. Terephthalicdihydrazide 4
Dimethyl terephthalate 2 (6.00 g, 0.03 mol), absolute ethanol
(60 mL) and 64 % hydrazine hydrate (20 mL) were heated under
reflux at 110 °C for 4 h. The dihydrazide (4) precipitated and was
filtered off. The filtrate was evaporated to dryness to give an
additional solid which was combined with the previous batch
and recrystallized from water to give a yellowish-white solid 4
(5.10 g, 85 %), m.p. > 350 °C; åmax: 3323 (NH), 1696 (CONH), 1650
(CONH) and 1622 (C=C aromatic); ÇH(DMSO-d6, 250 MHz)
10.57 (2H, s, 2 × CONH), 7.91(4H,s, H-aromatic), and 3.90 (4H, d,
2 × NH2); ÇC(DMSO-d6, 62.5 MHz) 165.0, 135.0 and 128.0.
4.5. 2,2’-(Benzene-1,4-diyldicarbonyl)dihydrazinecarbothioamide 5
Terephthalolyl dichloride 3 (10.00 g, 0.05 mol), THF (150 mL)
and thiosemicarbazide (17.90 g, 0.21 mol) was added over a
period of 15 min with an aid of stirring at room temperature.
Stirring continued at room temperature for 4 h when the colour
of the solution changed to green. The aqueous solution of
sodium bicarbonate 5 % (100 mL) was added dropwise while
stirring to give a solid precipitate. Filtered to give white crystal-
line material, recrystallized from methanol to give 5 (12.60 g.
83 %), m.p. 248–250 °C; åmax: 3275 (NH), 1669 (CO), 1618 (CN) and
1267 (CS); ÇH(DMSO-d6, 250 MHz) 10.49 (4H, s, 2 × NH-NH), 9.36
(4H, s, 2 × NH2), and 8.07 (4H, s, aromatic); ÇC(DMSO-d6,
62.5 MHz) 127.6, 135.2, 165.0, and 181.9 ; HRMS (ESI) calculated
for C10H12N6O2S2, 312.0462, found 312.0471 (M
+).
4.6. 5,5’-Benzene-1,4-diylbis(1,3,4-oxadiazole-2-thiol) 6
The hydrazide 4 (5.00 g, 0.02 mol), ethanol (60 mL), a solution
of NaOH (0.16 g, 0.04 mol) in ethanol (20 mL) was added and the
reaction mixture was stirred magnetically at room temperature.
Carbon disulphide (15 mL) was added dropwise and the reac-
tion mixture was refluxed at 80 °C for 3 h then allowed to cool
down to room temperature. The volatile solvent was removed
partially at room temperature, acidification with HCl (10 %) to
pH 5–6 to give a solid precipitate which was filtered under
vacuum and washed with an iced cold ethyl acetate. The filtrate
was extracted twice with ethyl acetate, then evaporated to dry-
ness to give a yellow solid which recrystallized from ethanol/
petroleum ether 40–60 to give a yellow solid 6 (5.08 g, 80 %), m.p.
> 350 °C; åmax: 3369(NH), 2360 (SH), 1583 (C=N), 1421 (CS) and
1152 (C-O); ÇH(DMSO-d6, 250 MHz) 10.32 (2H, s, 2 × NH), 7.81
(4H, s, aromatic), and 2.51 (2H, s, 2 × S-H); ÇC(DMSO-d6,
62.5 MHz) 206.0, 180.0, 164.0, 162.0; HRMS (ESI) calculated for
C10H6N4O2S2277.9932, found 277.9933 (M
+).
4.7. 5,5’-Benzene-1,4-diylbis(1H-1,2,4-triazole-3-thiol) 7a
Method A: compound 3 (6.90 g, 0.03 mol) was dissolved in
pyridine (60 mL), thiosemicarbazide (18.71 g, 0.06 mol) was
added gradually while stirring at 0 °C then continued for 24 h at
room temperature. Pyridine was removed under vacuum to
give a brownish solid. The latter was dissolved in methanol
(50 mL), freshly prepared sodium methoxide in methanol (Na,
3.00 g, 0.055 mol, methanol 15 mL) was added to it and refluxed
for 20 h. The solvent was removed under vacuum, water (50 mL)
was added cautiously and the mixture was acidified with ortho-
phosphoric acid. The pink precipitate formed filtered off to give
a solid which recrystallized from methanol/ethyl acetate to yield
white crystalline 7a (7.5 g, 72 %), m.p. > 350 °C; åmax: 3324(NH),
1584 (C=N) and 1421 (CS). The compound 7a was poorly soluble
in most organic solvents which made it difficult to perform
1H-NMR and 13C-NMR.
Method B: compound 5 (3.14 g, 0.01 mol) was dissolved in etha-
nol (200 mL). Ethanolic solution of KOH (KOH, 1.71 g, in ethanol
20 mL) was added and the mixture was refluxed for 15 h. The
bulk of the volatiles were removed under vacuum. The precipi-
tate formed was diluted with water (100 mL) and filtered. The
filtrate was acidified with orthophosphoric acid to give a white
solid which recrystallized to white crystalline 7a (2.6 g, 96 %),
m.p. > 350 °C; åmax: identical as above.
4.8. 5,5’-Benzene-1,4-diylbis[3-(methylsulfanyl)-1H-
1,2,4-triazole] 7b
Compound 7a (0.50 g, 0.01 mol) was dissolved in aqueous
sodium hydroxide solution (NaOH, 0.14 g, H2O 10 mL).
Dimethylsulfate (0.12 g, 0.01 mol) was added and the mixture
was refluxed for 1 h. Solvent removed under vacuum to give a
white solid, recrystallized from methanol to give white crystal-
line 7b (0.40 g, 75 %), m.p. >350 °C; åmax: 3324 (NH) and 1618
(C=N); ÇH(CDCl3, 250 MHz) 9.71(1H, s, NH), 9.45(s.1H, NH),
7.96 (4H, s, H-aromatic), 3.60 (3H, s, S–CH3) and 3.21 (3H, s,
S–CH3); ÇC(CDCl3, 62.5 MHz) 159.7, 151.2, 131.6, 127.6 and 15.12 ;
HRMS (ESI) calculated for C12H13N6S2 305.0643, found 305.0651
(MH+).
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Table 2 Inhibition of microorganisms by compounds 4–7a–c at minimum concentrations after 24 h.
Gram-positive Gram-negative
Compound S. aureus E. faecalis E. coli P. aeruginosa P. fluorescens
/µg mL–1 /µg mL–1 /µg mL–1 /µg mL–1 /µg mL–1
4 10.00 10.00 10.00 10.00 10.00
5 5.00 10.00 10.00 10.00 10.00
6 5.00 1.25 1.25 10.00 5.00
7a 10.00 10.00 10.00 1.25 10.00
7b 5.00 5.00 1.25 1.25 5.00
7c 10.00 5.00 0.63 5.00 5.00
4.9. 5,5’-Benzene-1,4-diylbis[1-methyl-3-(methylsulfanyl)-
1H-1,2,4-triazole] 7c
Compound 7a (1.40 g, 0.01 mol) was dissolved in aqueous po-
tassium hydroxide solution (KOH, 1.05 g, H2O 25 mL).
Dimethylsulfate (5.00 g, 0.03 mol) was added and the mixture
was stirred at room temperature for ½ h. Solvent removed under
vacuum to give a white solid, recrystallized from methanol to
give white crystalline 7c (1.20 g, 75 %), m.p.193–197 °C. åmax: 1618
(C=N); ÇH(CDCl3, 250 MHz) 8.21 (4H, s, aromatic), 3.90 (6H, s, 2 ×
N-CH3), and 2.95 (6H, s. 2 × S-CH3); ÇC(CDCl3, 62.5 MHz) 161.3,
153.6, 131.4, 126.2, 35.3 and 15.8 ; HRMS (APCI) calculated for
C14H17N6S2333.0956, found 333.0951 (MH
+).
4.10. 5,5’-Benzene-1,4-diylbis(1-amino-1H-1,2,4-triazole-3-thiol) 7d
Oxadiazole 6 (5.00 g, 0.02 mol), ethanol (20 mL) and hydrazine
hydrate 64 % (10 mL) were refluxed at 110 °C for 9 h. Ethanol was
removed under vacuum; the crude 7d was precipitated and
recrystallized from methanol to give colourless crystalline 7d
(4.00 g, 71 %). M.p. > 350 °C; åmax: 3433 (NH and NH2), 2360 (SH),
1636 (C=N) and 1423 (C=S); ÇH(DMSO-d6, 250 MHz) 9.80 (2H, s,
2 × NH), 7.85 (4H, s, aromatic), 5.80 (4H, s, 2 × NH2) and 3.35 (2H,
s, 2 × SH); ÇC(CDCl3, 62.5 MHz) 127.2, 131.3 and 151.8; HRMS
(ESI) calculated for C10H10N8S2 306.0470, found 306.0475 (M
+).
4.11. 2,3,4,6-Tetra-O-acetyl-~-D-glucopyranosyl Bromide 8
D-Glucose (12.50 g) was dissolved in acetic anhydride (50 mL),
perchloric acid (HClO4) (3.0 mL) was added dropwise to a stirred
solution. Temperature should not exceed 50 °C. The reaction
mixture was maintained at 30–40 °C for ½ h.The reaction mixture
was cooled to 20 °C, acetyl bromide (20 mL) was added dropwise
followed by water (5 mL) and stirring was continued for 2 h.
Chloroform (50 mL) was added followed by water (500 mL). The
organic layer was washed with dilute solution of sodium bicar-
bonate to neutrality and dried over anhydrous MgSO4. Filtration
and evaporation gave a solid substance which was recrystallized
from ether-petroleum ether 40–60, (v:v, 1:3) to give a colourless
crystalline solid 8 (25.00 g, 57.5 %), m.p. 83–87 °C (lit. 88–89 °C);53
åmax: 1744 (CO); ÇH(DMSO-d6, 250 MHz) 6.32 (1H, d,J 3.6, 1-H),
5.22 (3H, m, 2-H, 3-H, 4-H), 5.12 (1H, dd, J 3.27 and 3.6, 6-H), 4.81
(1H, dd, J 4.03 and 4.05, 6-H), 4.35 (1H, ddd, J 1.9, 4.05 and7.5,
5-H), 2.09, 2.07, 2.03 and 2.01 (12H, 4s, CH3CO-4 C2”, C3”, C4”,
C6”) ; ÇC(DMSO-d6, 62.5 MHz) 20.1, 21.9, 63.4, 68.0, 70.9, 79.1,
88.9, 159.3, 171.2; HRMS (ESI) calculated for C14H19BrO9
410.01212, found 410.0122 (M+).
4.12. 4-Bis[5’-S-(2”,3”,4”,6”-tetra-O-acetate-1”-S-glucosidyl)-
1’,3’,4’,oxadiazo-2’-yl]phenelyne 9
Bisoxadiazole 6 (0.28 g, 0.01 mol) was dissolved in dimethyl-
formamide (10 mL), triethylamine (0.4 mL) was added. The
bromide 8 (1.0 g, 0.01 mol) was added and the reaction mixture
was stirred at room temperature for 24 h during which the reac-
tion mixture changed into brown. The solvents were removed
under vacuum, water (50 mL) was added and extracted with
CH2Cl2 (3 × 50 mL). The organic layer was washed three times
with water (50 mL), dried over anhydrous MgSO4, filtered and
evaporated under vacuum to dryness at room temperature to
give 9 as a yellowish syrup which solidified on standing for a
week (0.75 g, 80 %); åmax: 1635 and 1585 (C=C and C=N), 1152
(C-O) and 1742 (C=O); ÇH(DMSO-d6, 250 MHz) 7.90 (4H, s,
aromatic-H), 5.81, 5.75 (1H, dd, J 3.65 and 3.65, 1”-H), 5.10–5.20
(3H, m, 2”-H, 3”-H, 4”H), 5.00, 4.70 (1H, dd, J 3.67 and 7.97, 6”H),
4.13 (1H, ddd, J 3.8 and4.05, 5”-H), 2.90, 2.80, 2.71 and 2.45 (12H,
4s, 4 × CH3CO- C”,C”,C4”,C6”) ; ÇC(DMSO-d6, 62.5 MHz) 20.1,
21.9, 31.1, 63.8, 68.0, 70.1, 73.0, 77.9, 79.1, 87.3, 88.9, 126.9, 129.1,
159.4, 164.0, 171.3; HRMS (ESI) calculated for C38H43N4O20S2
939.1912, found 939.1917 (MH+).
4.13. 1,4-Bis[5’-S-(2”,3”,4”,6”-tetra-O-acetate-1”-S-glucosidyl)-
1’H-1’,2’,4’-triazo-3’-yl]phenelyne 10
Method A: compound 7a (1.10 g, 0.01 mol) was dissolved in
chloroform (75 mL), aqueous solution of NaOH (0.40 g, NaOH in
H2O, 25 mL) was added. Benzyl triethyl ammonium chloride
(4.63 g and bromoglucoside tetra-acetate 8 (4.00 g were added to
the chloroform solution and the mixture was heated under
reflux for 48 h with vigorous stirring. The two layers formed
were separated. The aqueous phase was extracted with chloro-
form (20 mL) and the extract was added to the organic phase.
The latter was dried over anhydrous MgSO4, filtered and evapo-
rated under vacuum on a water bath to give brownish syrup so-
lidified on standing 10 (3.77 g, 43 %); åmax 3330 (NH), 1725 (broad
C=O) and 1620 (CN); ÇH(DMSO-d6, 250 MHz) 10.31 (2H, s, 2NH),
8.10, 7.97 (4H, s, 4H- phenylene), 6.20 (1H, d, J 3.75, 1”-H), 5.30
(3H, m, 2”-H, 3”-H, 4”-H), 5.00, 4.50 (2H, dddd, J 3.61,3.75,3.0 and
3.37, 2–6”-H), 4.35 (1H, ddd, J 3.37,3.75 and 4.55, 5”-H), 2.90, 2.70,
2.51 and 2.22 (12H, 4s, 4 × CH3CO- C2”, C3”, C4”, C6”); ÇC
(DMSO-d6, 62.5 MHz) 20.4, 22.2, 32.8, 65.1, 69.0, 70.2, 72.0, 77.1,
78.7, 87.0, 89.3, 128.7, 159.9, 171.3; HRMS (ESI) calculated for
C38H45N6O18S2 937.2232, found 937.2238 (MH
+).
Method B: compound 7a (1.38 g, 0.05 mol), was dissolved in
DMF (15 mL), triethylamine (TEA) (1.0 mL, 0.01 mol) and added
to it bromoglucosidetetraacetate 8 (4.93 g, 0.01 mol). The mixture
was stirred at room temperature for 24 h. Volatile solvents were
removed under vacuum at low temperature. The residual syrup
was dissolved in dichloromethane (50 mL) and washed twice
with H2O (20 mL). The organic layer dried over anhydrous
MgSO4, filtered and evaporated to dryness at low temperature
to give a brownish syrup solidified on standing 10 (4.70 g, 60 %).
IR and 1H-NMR were similar to that found in method A.
5. Antimicrobial Susceptibility Testing45
5.1. Antibacterial Tests
A disk diffusion assay according to the standard protocols
(NCCLS, 2003, 2005; CLSI, 2006) was used42–44 to determine the
susceptibility of two Gram-positive bacteria Staphylococcus aureus
ATCC 25923 and Enterococcus faecalis ATTC 29212 and three
Gram-negative bacteria Escherichia coli ATCC 25924, Pseudomonas
aeruginosa ATCC 10145, Pseudomonas fluorescens using Genta-
mycin and Cefotaxim as references.The bacterial suspension
(in 0.9 % NaCl) turbidity were adjusted to 0.5 McFarland, then
the suspensions were spread with a sterile cotton swab
confluently over the entire surface of Mueller Hinton agar
(Merck, Germany).
The filter paper disk method was performed in duplicate
using fresh Mueller Hinton agar medium. This agar medium
was inoculated with 0.5 mL of cultures containing about 106
CFU/mL. Filter paper disks (5 mm diameter) saturated with
dimethylsulphoxide (10 % DMSO v:v) solutions of each compound
was placed on the indicated agar medium. The incubation time
was 24 h at 37 °C. The blank test disk with DMSO was used.
Inhibitory activity was evaluated by measuring the diameter of
clear zone observed around the disk in mm.
5.2. The Minimum Inhibition Concentration (MIC) Tests
Each 1 mL of the original concentration (10 µg mL–1) in DMSO
of the compounds 4, 5, 6 and 7a–c were diluted with DMSO five
times in test tubes to 5.0, 2.5, 1.25, 0.625, 0.312 µg mL–1 and optical
density at 600 nm was measured at 24 h.
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